Sell alert! Why this expert is ditching Qantas shares for this ASX 200 defence stock

A leading expert is selling Qantas shares and buying this surging ASX 200 defence stock instead. But why?

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Qantas Airways Ltd (ASX: QAN) shares are lifting off today.

Shares in the S&P/ASX 200 Index (ASX: XJO) airline stock closed yesterday trading for $10.29. During the Wednesday lunch hour, shares are changing hands for $10.54 apiece, up 2.4%.

For some context, the ASX 200 is up 0.3% at this same time.

Following a strong rebound commencing in late May, Qantas shares have now recovered almost all of the 23.5% losses suffered in the first month following the outbreak of the Iran war on 28 February.

Those losses were partly driven by concerns that the conflict could crimp international travel demand. Surging oil prices also saw investors reach for their sell buttons, with higher jet fuel costs expected to take a bite out of the airline's profits and upcoming dividends.

Looking ahead, MPC Markets' Mark Gardner believes the recent rebound in the ASX 200 airline makes now an opportune time to sell (courtesy of The Bull).

Here's why.

Pilot on the phone looking distraught.

Image source: Getty Images

Time to sell Qantas shares?

"The airline giant is exposed to volatile jet fuel prices in response to the Middle East conflict," Gardner said.

He noted:

Although QAN hedged about 90% of its exposure to crude oil prices in the second half of 2026, it was exposed to movements in jet refining margins. Qantas announced in April that jet refining margins had increased from US$20 a barrel in February to a peak of around US$120 a barrel.

On 14 April, amid the surging oil prices that followed the closure of the vital Strait of Hormuz shipping lane, Qantas increased its second-half jet fuel cost guidance to between $3.1 billion and $3.3 billion. That's potentially $800 million more than the airline had reported six weeks earlier, shortly before the outbreak of hostilities.

Summarising his sell recommendation on Qantas shares, Gardner concluded, "The company announced capacity adjustments and fare increases to mitigate the impact of the Middle East conflict. Higher fares may impact demand. We would be inclined to sell into strength."

Consider this ASX 200 defence stock instead

While Gardner is bearish on the medium-term outlook for Qantas shares, he issued a buy recommendation for remote weapon systems developer Electro Optic Systems Holdings Ltd (ASX: EOS).

Up 2.% today at $7.71 a share, shares in the ASX 200 defence stock have surged 81.9% in 12 months. Though shares remain down 37.4% since notching a record closing high on 2 June.

According to Gardner, that pullback represents a buying opportunity today.

Gardner said:

This counter drone and laser weapons group had an order book of $846 million at June 30, 2026, an 84% increase since December 31, 2025. In May, it completed the acquisition of the MARSS Group, a provider of artificial intelligence enabled command and control systems for counter drone capability.

The company upgraded full year 2026 revenue guidance to between $280 million and $300 million, excluding MARRS.

The stock has fallen significantly between June 2 and July 30 to the point it has been materially over-sold, in our view. Investors can consider buying EOS on weakness.

Motley Fool contributor Bernd Struben has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended Electro Optic Systems. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Broker Notes

Medical workers examine an x-ray or scan in a hospital laboratory.
Broker Notes

Up 64%, 3 reasons this expert predicts Pro Medicus shares will keep on giving

A leading expert forecasts more outperformance from the surging Pro Medicus share price.

Read more »

Business man marking buy on board and underlining it.
Broker Notes

Leading brokers name 3 ASX shares to buy today

Brokers believe that now could be the time to buy these shares.

Read more »

A scientist in a white coat and glasses puts her arms in the air in a sign of strength and success.
Broker Notes

Morgans tips a 600%+ return for this ASX biotech stock

Good clinical study progress has the broker bullish on this company.

Read more »

Wlorker on a laptop on top of solar panels.
Broker Notes

Up 8%, should I buy the rebound in Origin Energy shares today?

A leading analyst provides his forecast for Origin Energy’s rebounding shares.

Read more »

A woman stands in a field and raises her arms to welcome a golden sunset.
Gold

4 ASX 200 gold shares to buy: Experts

Experts explain their buy ratings following these miners' June quarter reports.

Read more »

Three balls at various places on a cycle.
Broker Notes

6 ASX uranium shares to buy ahead of yellow cake rising to US$200 per pound: experts

This broker tips 83% to 295% upside over 12 months for its 6 top ASX uranium share picks.

Read more »

A hipster-looking man with bushy beard and multiple arm tattoos sits on the floor against a sofa reading a tablet with his hand on his chin as though he is deep in thought.
Broker Notes

Buy, hold, sell: Capstone Copper, Lindsay Australia, Woodside shares

Let's take a look at three fresh buy, hold, and sell calls from the experts. 

Read more »

A man in a business suit scratches his head looking at a graph that started high then dips, then starts to go up again like a rollercoaster.
Broker Notes

Down 23% and 58%, should I buy TechnologyOne and Xero shares now?

A leading expert provides his forecasts for TechnologyOne and Xero shares.

Read more »